An2 Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $108k | 22k | 4.84 |
| 2024-03-31 | $416 | 128 | 3.25 |
| 2023-12-31 | $2.6k | 126 | 20.49 |
| 2023-09-30 | $996 | 62 | 16.08 |
| 2023-06-30 | $298 | 35 | 8.51 |
| 2022-09-30 | $0 | 27 | 0.00 |
| 2022-06-30 | $999 | 73 | 13.70 |